Results 101 to 110 of about 33,477 (277)
IntroductionProgestin resistance has emerged as a significant barrier to the conservative management of endometrial cancer (EC). The mechanisms underlying progestin resistance in endocrine therapy remain incompletely understood.
Ye Yang +13 more
doaj +1 more source
Estrogen Plus Progestin Hormone Therapy and Ovarian Cancer
Background: Menopausal estrogen-alone therapy is a risk factor for endometrial and ovarian cancers. When a progestin is included with the estrogen daily (continuous estrogen-progestin combined therapy), there is no increased risk of endometrial cancer ...
Webb, Penelope M. +57 more
core +1 more source
HUBUNGAN KECEMASAN DENGAN KETEPATAN KUNJUNGAN ULANG AKSEPTOR KB SUNTIK PROGESTIN PADA MASA PENDEMI COVID-19 DI KLINIK PRATAMA PMI DIY [PDF]
HUBUNGAN KECEMASAN DENGAN KETEPATAN KUNJUNGAN ULANG AKSEPTOR KB SUNTIK PROGESTIN PADA MASA PENDEMI COVID-19 DI KLINIK PRATAMA PMI DIY Nofa Rositai1, Heni Puji Wahyuningsih 2, Dwiana Estiwidani3 1,2,3 Jurusan Kebidanan Poltekkes Kemenkes Yogyakarta
Nofa Rosita
core
ABSTRACT Objective To analyse prescribing trends for oral and transdermal hormone replacement therapy (HRT) in Wales from 1996 to 2023, including predictors of discontinuation within one year of initiation. Design Observational study using the Secure Anonymised Information Linkage (SAIL) databank.
Robin Andrews +3 more
wiley +1 more source
ABSTRACT Surgical menopause, the removal of both ovaries prior to natural menopause, may impact short‐and long‐term physical and emotional health. An increasingly common cause of surgical menopause is risk‐reducing salpingo‐oophorectomy (RRSO) in those at high inherited risk of ovarian cancer.
Sarah A. L. Price +12 more
wiley +1 more source
Progestin Concentrations Alter Follicle Characteristics and May Affect Quality of Oocytes (Eggs) [PDF]
Cows were treated with two progestin concentrations to develop ovulatory follicles exposed to different hormone environments. Cows were assigned to Control Group receiving a CIDR for 7 days (4-6 ng/ml of progestin), or to MGA-14 Group receiving 5mg/head ...
Longfellow, Robyn A. +14 more
core
Nuclear progestin receptor-like component in human cervical tissue
To study progestin action in human glandular cervix, we extracted the nuclear pellet with 0.5 M KCl and immediately adsorbed a progestin-binding receptor-like component to hydroxylapatite.
C. A. Pinkert, J. A. Holt, M. A. Lorincz
core +1 more source
Data from: Nuclear Progestin Receptor Mediated Linkage of Blood Coagulation and Ovulation
Supplemntal information for a manuscript entitiled "Nuclear Progestin Receptor Mediated Linkage of Blood Coagulation and Ovulation"
Yong Zhu (8726905) +6 more
core +1 more source
Advent of NK3R Antagonists for the Treatment of Menopausal Hot Flushes: A Narrative Review
ABSTRACT The menopause transition is marked by symptoms predominantly attributed to declining oestrogen levels. Approximately 80% of women experience associated symptoms, and 25% experience severe symptoms. The commonest are vasomotor symptoms (VMS), collectively referring to hot flushes and/or night sweats.
Aaran H. Patel +5 more
wiley +1 more source
ABSTRACT Background Hormone Replacement Therapy (HRT) is used to manage menopausal symptoms, particularly vasomotor symptoms (VMS). HRT prescribing rates are rising, but most women will eventually discontinue. Objectives To explore the experiences of women stopping HRT, why women restart HRT, and the HCPs advising them. Search Strategy Embase, MEDLINE,
Sarah Bunnewell +4 more
wiley +1 more source

